Skip to content

Obsidio is now a part of Boston Scientific. Learn More

Technology
Applications
About Us
Press
Publications

Contact

Press

Obsidio, Inc. Expands Clinical Advisory Board With Two New Members

November 2, 2021

View Full Story

Technology
Applications
About Us
Press
Publications

© Copyright 2022 Obsidio Privacy Policy Web Design by Beam & Hinge

Twitter
Linked-in

Obsidio's portfolio of products is under development and does not have marketing clearance or approval in any market at this time. For investigational use only. Not available for sale.